We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Resources > Listicles > Content Piece

Ketamine, MDMA, DMT and Psilocybin: A Closer Look at Four Psychedelics

By Ruairi J Mackenzie

Published: Sep 29, 2021   

Ketamine, MDMA, DMT, and psilocybin are four psychedelics that are making waves in psychiatric medicine. While they are all banned or restricted in the industrialized west, these compounds have moved past decades of stigma to become well-studied therapeutics either approved or in trial to treat mental health conditions such as major depression and post-traumatic stress disorder.

Download this listicle to learn:

  • The backgrounds of these psychedelics
  • Their properties and potential mechanisms of action
  • The conditions that they could help treat


Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter